Intestinal de novo phosphatidylcholine synthesis is required for dietary lipid absorption and metabolic homeostasis
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INTRODUCTION
Phospholipids form the matrix of biological membranes, provide precursors for a variety of signaling molecules, and allow assembly and secretion of lipoproteins (1).
Phosphatidylcholine (PC) is the primary phospholipid in eukaryotic cells (1). The amphitropic enzyme CTP: phosphocholine cytidylyltransferase (CT) regulates de novo PC synthesis in response to changes in membrane lipid composition in all nucleated mammalian cells (2) . Global deletion of CTα (encoded by Pcyt1a) is embryonic lethal in mice, reflecting the essential role of membrane biogenesis during development (3) . Mice lacking CTα in the liver have impaired very-low-density lipoprotein (VLDL) secretion and accumulate neutral lipids in hepatocytes (4) despite the presence of a second route for hepatic PC synthesis via the methylation of phosphatidylethanolamine (PE) by phosphatidylethanolamine-N-methyltransferase (PEMT).
Similarly, CTα cannot compensate for the loss of PEMT in generating PC for VLDL assembly (5) .
Intestinal PC can be derived from the diet, bile, circulating lipoproteins, and from local de novo synthesis. Dietary and biliary PC is hydrolyzed in the intestinal lumen by phospholipase A2 to lyso-PC and fatty acids before being absorbed into enterocytes, delivered to the 4 secretion (11) . Therefore, while the re-acylation of lyso-PC derived from the intestinal lumen is important for chylomicron production, the precise contribution that intestinal de novo PC synthesis makes to this process is unknown.
In the present study we hypothesized that loss of intestinal CTα activity would cause TG accumulation in enterocytes due to insufficient supply of PC for chylomicron assembly.
However, we unexpectedly found that loss of intestinal de novo PC synthesis impairs passage of fatty acids from the intestinal lumen into enterocytes in the setting of a high fat diet (HFD), but not a chow diet. Fat malabsorption is linked to the repression of genes involved in fatty acid uptake, enhanced postprandial enteroendocrine hormone secretion, and reduced adiposity.
Furthermore, we show that loss of intestinal CTα promotes biliary bile acid and lipid secretion by accelerating enterohepatic bile acid cycling. Our data provide evidence of a specific requirement for intestinal de novo PC synthesis in the maintenance of intestinal metabolic functions and show that the re-acylation of lyso-PC from extra-intestinal sources is insufficient to maintain metabolic function during HFD feeding.
MATERIALS AND METHODS
Generation of mice with intestine-specific deletion of Pcyt1a
Mice carrying a floxed Pcyt1a locus (Pcyt1a LoxP/LoxP ) on a C57BL/6J background were crossed with mice expressing a tamoxifen-inducible Cre-recombinase transgene under the control of a villin promoter (villin-CreER T2 ) (12) to generate Pcyt1a LoxP/WT ;villin-CreER T2 mice (with the capacity to induce a heterozygous deletion of intestinal CTα after tamoxifen treatment).
Subsequent cross-breeding of Pcyt1a LoxP/WT ;villin-CreER T2 mice resulted in the generation of Pcyt1a LoxP/LoxP ;villin-CreER T2 mice (with the capacity to induce a homozygous deletion of intestinal CTα after tamoxifen treatment). Genomic DNA was extracted from tail biopsies with a DNeasy Blood and Tissue Kit (Qiagen, UK). PCR products were identified on a 3% agarose gel (floxed Pcyt1a band) or a 1.5% agarose gel (Villin Cre-inducible band). Cre was induced in 8-12-week-old male or female mice by intraperitoneal injection of tamoxifen (1mg/day in sunflower oil for 5 days; Sigma, St. Louis, MO), while tamoxifen-treated Pcyt1a LoxP/LoxP mice were used as controls. Mice were fed a chow diet (5001, Lab Diet, St. Louis, MO) or a semipurified HFD containing 40% kilocalories as fat ( Supplementary Table S1 ). Mice were housed in a temperature-controlled room with 12-h light/dark cycle and free access to food and water.
Samples were collected after a 10-h fast or after overnight fasting followed by 2-h re-feeding, unless otherwise stated. Small intestines were excised, flushed with phosphate buffered saline (PBS) containing protease inhibitor cocktail (Sigma, St. Louis, MO), and kept on ice. The small intestine was divided into 3 portions of length ratio 1:3:2 (corresponding to duodenum: jejunum: ileum) before jejunum sections were fixed in 10% neutral-buffered formalin for histology.
Epithelial cells were collected in liquid nitrogen after segments were opened longitudinally. The University of Alberta's Institutional Animal Care Committee approved all animal procedures, which were in accordance with guidelines of the Canadian Council on Animal Care.
Microscopy
Formalin-fixed, paraffin-embedded tissue slices (5µm thick) were stained with hematoxylin and eosin (H&E) and visualized with a light microscope. For electron microscopy, 2cm jejunal rings were fixed with 2% paraformaldehyde and 2.5% glutaraldehyde in 0.1M phosphate buffer (pH 7.2). Sections were cryo-sectioned with an ultramicrotome (Ultracut E, Reichert-Jung) equipped 6 with an FC4D attachment, and images were obtained using a Philips 410 transmission electron microscope.
mRNA isolation and quantification by PCR
Total RNA was isolated from intestinal scrapings or liver using Trizol (Invitrogen, CA, USA).
RNA was reversed-transcribed using Superscript II (Invitrogen, CA, USA). Quantitative PCR was run on an Applied Biosystems StepOne Plus for 40 cycles using a Power SYBR Green PCR Master Mix (Applied Biosystems, MA, USA), in triplicate. Relative mRNA expression was normalized to cyclophilin. Quantitation was performed using the standard curves method. Primer sequences are listed in Supplementary Table S2 .
Fatty acid absorption
Intestinal fatty acid absorption was quantified as described previously (13) CA) after separation of the fractions by the method of Folch (14) .
Gallbladder cannulations and bile measurements
For gallbladder cannulations, male mice were anesthetized by intraperitoneal injection of ketamine (100mg/kg)/ xylazine (10mg/kg). Gallbladders were cannulated with silastic tubing (Dow Corning, MI; internal diameter 0.5mm) after ligation of the common bile duct beside the duodenum. Mice were placed in a humidified incubator and bile was collected for 30 mins in pre-weighed vials. Bile acid species composition (including taurohyodeoxycholic acid (THDCA), tauro-β-muricholic acid (TB-MCA), tauro-α-muricholic acid (TA-MCA), βmuricholic acid (β-MCA), taurodeoxycholic acid (TDCA), taurochenodeoxycholic acid 8 (TCDCA), taurocholic acid (TCA), tauroursodeoxycholic acid (TUDCA) and cholic acid (CA)) was determined by liquid chromatography tandem mass spectrometry (LC-MS/MS) as described previously (15) . The hydrophobicity of bile acids was determined according to the method of Heuman (16) . Biliary lipids were extracted by the method of Folch (14) . Biliary phospholipid concentrations were assessed by phosphorous assay, as described previously (17) . Biliary cholesterol concentrations were measured with a commercially available kit (WAKO Chemicals, USA). Biliary secretion rates were calculated by multiplying biliary bile acid, phospholipid, or cholesterol concentrations by bile flow (µL/min). Bile acid concentrations in feces and plasma were determined by enzymatic fluorometric assay (18) . Total protein concentrations of tissue homogenates were determined by bicinchoninic acid assay before tissue lipids were extracted from homogenates (1mg/ml) by the method of Folch (14) . PC and phosphatidylethanolamine (PE) were separated by thin layer chromatography using the solvent system chloroform:methanol:acetic acid:water (50:30:8:4). Bands were visualized after exposure to iodine and measured by phosphorous assay, as described previously (17) . Intestinal TG concentrations were measured using a commercially available kit (Sekisui Diagnostics, MA, USA). The relative abundance of PC species in jejunal epithelial cells was measured by mass spectrometry at The Metabolomics Innovation Centre, University of Alberta. To analyze the fatty 9 acid composition of intestinal PC, lipids were extracted from intestinal scrapings and separated by thin-layer chromatography as described above. PC bands were recovered from the plates and converted to fatty acid methyl esters by incubation with 2 ml of hexane (Sigma Aldrich, 293253) and 1.5ml boron trifluoride (Sigma-Aldrich, B1252) in methanol for 1 h at 110 °C. Fatty acid methyl esters were then analyzed by gas-liquid chromatography (results are shown as the percentage of total fatty acids measured). Intestinal non-esterified cholesterol and cholesterol esters were measured by gas-liquid chromatography with flame ionization detection (GC-FID) after derivatization with bis(trimethylsilyl)trifluoroacetamide and adjustment of peaks with the internal standard tridecanoin, as described previously (19) . Fecal samples (50mg) were dried and ground to a powder before extraction of lipids by the method of Folch (14) . Non-esterified fatty acid and cholesterol concentrations in feces of female mice collected over 72 h were determined with commercially available kits (Wako Chemicals, USA).
Plasma, tissue, and fecal lipid analysis
Measurement of intestinal CT activity
Intestinal CTα activity was determined by measuring the conversion of [ 3 H]phosphocholine into [ 3 H]CDP-choline, as described previously (4) .
Plasma metabolite measurements
Blood glucose was measured from the tail vein with a glucometer (Accu-chek, Roche, Switzerland) after a 10-h fast, after 2 h re-feeding or after 2 h re-feeding followed by an oral gavage of glucose (2mg/g body weight). Blood was collected by cardiac puncture in tubes containing EDTA, dipeptidyl peptidase 4 inhibitor (EMD Millipore, MA, USA) and Complete ® general protease inhibitor (Sigma, MO, USA) before being centrifuged at 3000g for 10 minutes to obtain plasma. Plasma insulin (Meso Scale Diagnostics, MD, USA), leptin (Meso Scale 10 Diagnostics, MD, USA), active GLP-1 (EMD Millipore, MA, USA), PYY (Crystal Chem IL, USA), and FGF21 (Abcam, Cambridge, UK) were measured by enzyme-linked immunosorbent assay, according to the manufacturer's instructions. Plasma (4µL) was resolved on a sodium dodecyl sulfate polyacrylamide gel (5% gel for ApoB and 10% for ApoA1). Proteins were transferred to a to a polyvinylidene difluoride membrane and probed with either anti-Apolipoprotein B (dilution 1:7500, AB742; Chemicon, MA, USA) or Anti-Apolipoprotein A1 (dilution 1:2000; K23001R, BioDesign/Meridian). ApoB and ApoA1 were run on separate gels.
Immunoreactive proteins were detected with Enhanced ChemiLuminescence (ECL; Amersham, GE Healthcare, UK), and blots were imaged with a ChemiDoc MP Imager, (Bio-rad Laboratories, CA, USA).
Statistics
Data are expressed as mean ± standard error of the mean using Graphpad Prism 7 (GraphPad Software, La Jolla, CA); p < 0.05 was considered statistically significant. Student's t-test was used to compare two independent groups. A one-way ANOVA was used when comparing 3 groups with one experimental outcome. A two-way ANOVA with Bonferroni post-test was used to determine the effect of genotype and time on an experimental outcome. Loss of intestinal CTα did not impact survival of the mice fed the chow diet, and body mass of CTα IKO mice was comparable to that of controls after 6 weeks (Fig. 1C ). Furthermore, histological examination of H&E-stained jejunum sections at 6 weeks after Cre induction revealed no overt morphological abnormalities in CTα IKO intestines compared to control intestines ( Fig. 1D ). This finding suggests that intestinal CTα activity is not required for maintenance of epithelial cell turnover in adult mice. PC concentrations were lower in the jejunum and ileum of CTα IKO mice compared to controls after an oil challenge ( Fig. 1E ).
RESULTS
Intestinal PC concentrations are reduced in CTα
Furthermore, PE concentrations were higher in the jejunum of CTα IKO mice (Fig. 1F ). This resulted in a relatively large decrease in the molar ratio of PC-to-PE in the intestines of CTα IKO mice ( Fig. 1G ). Fasting plasma cholesterol concentrations ( Fig. 1H ) were significantly lower in CTα IKO mice fed the chow diet, while fasting plasma TG ( Fig. 1I ), insulin and blood glucose concentrations (not shown) were unchanged compared to control mice.
Unexpectedly, despite the absence of intestinal CTα activity and a dramatic decrease in the PC/PE ratio of intestinal membranes, TG appearance in plasma was comparable between CTα IKO mice and control mice after an oral bolus of olive oil (Fig. 1J ). This finding suggests that, in 12 contrast to the liver where 'new' PC synthesis is required for VLDL secretion (4), intestinal de novo PC synthesis is dispensable for chylomicron secretion in the setting of a low-fat diet. These results also suggest that PC supplied to the intestine in bile is sufficient for chylomicron formation and secretion under these conditions. HFD feeding initially induces rapid weight loss, while chronic HFD feeding reduces weight gain, in CTα IKO mice
We hypothesized that feeding mice a HFD would increase demand for lipid droplet and chylomicron PC and therefore induce more pronounced changes to the intestinal epithelium of CTα IKO mice. Analysis of 3 independent experiments showed that 26% of CTα IKO mice (5 of 19) lost ~25% body weight and displayed steatorrhea between days 4 and 5 following initiation of the HFD, forcing termination of these mice under protocol requirements ( Fig. 2A) . Interestingly, the remaining 74% of CTα IKO mice experienced only modest weight loss but had significantly less visceral fat mass and lower plasma leptin concentrations than did control mice on day 6 following initiation of the HFD (Fig. 2B and 2C ). Weight loss in CTα IKO mice coincided with reduced food intake (2.76 g ± 0.25 by control mice compared to 1.36 g ± 0.21 by CTα IKO mice between 48 and 72 h after initiation of the HFD, P=0.0009).
The CTα IKO mice fed a HFD for 50 days gained 20% less body weight and had 40% less visceral fat mass compared to controls ( Fig. 2D and 2E ). The lower food intake observed in CTα IKO mice compared to control mice in the first week following initiation of the HFD appeared to be an acute response to the diet, as food intake was similar between CTα IKO mice and control mice by week 6 following HFD initiation (2.257± 0.16 g/day for control mice compared to 2.034 ± 0.17 g/day for CTα IKO mice, P=0.36). Nevertheless, fasting blood glucose was significantly lower in CTα IKO mice (Fig. 2F) . In contrast to liver-specific CTα knockout mice (4), fasting 13 plasma TG and cholesterol concentrations were not reduced in CTα IKO mice after being fed a HFD for 6 days or 50 days ( Fig. 2G and 2H ). Taken together, these data show that HFD feeding induces weight loss, while chronic feeding reduces weight gain in CTα IKO mice.
Loss of intestinal CTα reduces chylomicron lipidation during HFD feeding
To determine whether impaired dietary lipid absorption contributed to the acute weight loss in CTα IKO mice fed the HFD, we assessed postprandial plasma lipid concentrations. Control and CTα IKO mice were fasted overnight on day 3 following initiation of the HFD (prior to onset of severe weight loss) before re-feeding them for 2 h. Food intake was similar between CTα IKO mice and control mice during HFD re-feeding (not shown). Plasma TG concentrations were 60% lower and plasma non-esterified fatty acid concentrations were 30% lower in CTα IKO mice compared to controls after 2 h HFD re-feeding ( Fig. 3A) . Furthermore, CTα IKO mice had markedly less TG in the largest lipoprotein fraction compared to controls (Fig. 3B) . Interestingly, despite a dramatic difference in plasma TG concentrations between genotypes after re-feeding, plasma ApoB concentrations were not different ( Fig. 3C ). This finding strongly suggests that lipidation of the intestine-derived lipoprotein particles was impaired in CTα IKO mice, whereas the number of particles secreted was not reduced. Total plasma cholesterol concentrations were similar between CTα IKO mice and control mice after HFD re-feeding ( Fig. 3A ). However, ). Lower plasma TG after re-feeding was also observed in CTα IKO mice compared to controls fed a HFD for 6 weeks (1.14 ± 0.06 mmol/L in control mice compared to 0.83± 0.09 mmol/L in CTα IKO mice, P=0.03). Taken together, these data show that the intestine secretes TG-poor ApoB-containing particles in the absence of de novo PC synthesis.
Loss of intestinal CTα impairs fatty acid uptake from the intestinal lumen into enterocytes
We hypothesized that impaired intestinal TG secretion in CTα IKO mice was due to TG accumulation in enterocytes. However, CTα IKO mice had significantly lower jejunal TG concentrations than control mice after fasting and re-feeding ( Fig. 4A and 4B) . To track the spatial distribution of fatty acid uptake in the small intestine, we gavaged mice with [ 3 H]-labeled triolein. The radioactivity in the mid-intestine of CTα IKO mice, where fatty acid absorption is typically highest, was strikingly lower than in control mice (Fig. 4C ). As expected based on previous results, appearance of [ 3 H]-label in plasma was significantly blunted in CTα IKO mice ( Fig. 4D) . Taken together, these data indicate that loss of intestinal CTα impairs fatty acid uptake from the intestinal lumen into enterocytes in the setting of a HFD.
Histological examination of jejunal sections 2 h after a bolus of olive oil revealed fewer lipid droplets in enterocytes of CTα IKO mice compared to control mice fed the HFD (Fig. 4E ).
We also detected markedly fewer fluorescent lipid droplets in enterocytes of CTα IKO mice gavaged with Bodipy-labeled fatty acids (Fig. 4F) . Moreover, electron microscopy showed a general absence of cytosolic lipid droplets in HFD-fed CTα IKO enterocytes 2 h after an oil challenge ( Fig. 4G ). Consistent with lower fatty acid concentrations in enterocytes, the mRNA levels of monoacylglycerol O-acyltransferase 2 (Mogat2), diacylglycerol O-acyltransferase 2 (Dgat2) and lipid droplet-associated abhydrolase domain containing 5 (Abhd5) and cell deathinducing DFFA-like effector c (Cidec) were significantly lower in CTα IKO intestines 2 h after a meal (Fig. 4H) . These data suggest that impairment of intestinal PC synthesis reduces fatty acid uptake from the intestinal lumen and thereby limits fatty acid supply for lipid droplet and chylomicron formation. In further support of impaired fat absorption, non-esterified fatty acids were elevated in feces of CTα IKO mice compared to control mice (Fig. 4I ).
Loss of intestinal CTα impairs intestinal cholesterol absorption
Cholesterol concentrations were also significantly higher in feces of CTα IKO mice compared to control mice (Fig. 5A) . sterols was not different between genotypes ( Fig. 5D and 5E ), suggesting that hepatic cholesterol uptake was unaltered by loss of intestinal CTα. Furthermore, there was no difference in appearance of [ 3 H] or [ 14 C] in fecal bile salts between genotypes, suggesting that hepatic bile acid synthesis was not changed in response to reduced intestinal cholesterol absorption in CTα IKO mice ( Fig. 5F and 5G ). Despite impaired cholesterol absorption, jejunal cholesterol and cholesterol ester concentrations were unchanged in CTα IKO mice relative to controls ( Fig. 5H and   5I ). Accordingly, mRNA abundance of several genes linked to cholesterol biosynthesis, including mevalonate kinase (Mvk), farnesyl diphosphate synthase (Fdps), cytochrome P450, family 51 (Cyp51) and NAD(P) dependent steroid dehydrogenase-like (Nsdhl), were induced in the jejunum of CTα IKO mice relative to controls (Fig. 5J ). Induction of intestinal cholesterol biosynthesis in CTα IKO mice might be a compensatory response to impaired cholesterol absorption, or it might be due to altered intestinal phospholipid homeostasis in epithelial cells, as has recently been described (20) .
Impaired lipid absorption in CTα IKO mice is linked to reduced expression of plasma membrane lipid transporters
Microvillus length and structure were comparable between genotypes, suggesting that lipid malabsorption in CTα IKO mice is not due to structural damage to the intestinal epithelium ( Fig. 6A ). Intestinal Lpcat3 deletion in mice reduces passive lipid diffusion into enterocytes by reducing the incorporation of polyunsaturated fatty acids into intestinal PC (9, 10). The mRNA levels of Lpcat3 were not altered in CTα IKO mice relative to controls (Fig. 6B ). As expected, jejunal PC concentrations were significantly lower in CTα IKO mice re-fed the HFD, while PE concentrations were unchanged compared to controls ( Fig. 6C and Fig 6D) . However, the relative abundance of PC molecular species as measured by mass spectrometry was only minimally different between genotypes, with small increases in the relative abundance of PC (36:2) and PC (38:3) observed in CTα IKO mice (Fig. 6E ). To validate our mass spectrometry results we performed gas-liquid chromatography analysis of the acyl chain constituents of PC and confirmed that the composition of fatty acids acylated to PC in the proximal intestine was comparable between genotypes ( Fig. 6F) . Therefore, impaired lipid absorption in CTα IKO mice is not due to changes in the relative abundance of PC molecular species as observed in mice deficient in intestinal Lpcat3. However, altered PC/PE ratio of intestinal membranes may impair passive lipid diffusion into enterocytes of CTα IKO mice.
The membrane lipid transporters Cluster-determinant 36 (Cd36), Solute Carrier Family 27 Member 4 (Slc27a4; Fatty acid transport protein 4) and NPC1 like intracellular cholesterol transporter 1 (Npc1l1) promote lipid absorption in intestinal epithelial cells (21-23). The mRNA levels of jejunal Cd36 were dramatically lower in CTα IKO mice relative to control mice (Fig. 6F ).
Furthermore, Slc27a4 and Npc1l1 mRNA levels were modestly lower in CTα IKO mice (Fig. 5F ).
Therefore, reduced expression of membrane transporters involved in intestinal lipid uptake relative to controls may at least partially account for impaired lipid absorption in CTα IKO mice.
Loss of intestinal CTα enhances postprandial enteroendocrine hormone secretion
Dietary fatty acids in the lumen of the distal intestine stimulate secretion of enteroendocrine hormones including glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) from L cells to control food intake and satiety (24) . Since CTα IKO mice have impaired fatty acid absorption in the proximal small intestine resulting in increased fatty acid content of feces, we hypothesized that the higher abundance of fatty acids in the distal small intestine of CTα IKO mice would trigger GLP-1 and PYY secretion. CTα IKO mice had strikingly elevated active GLP-1 (~9fold) and PYY (~9-fold) in plasma 2 h after re-feeding the HFD (Fig. 7A and 7B) . A major physiological function of GLP-1 is to promote insulin secretion from the pancreas (24) . Accordingly, CTα IKO mice had a strong trend towards higher postprandial plasma insulin concentrations compared to controls (Fig. 7C ). Fibroblast-like growth factor 21 (FGF21) is a hepatokine with multiple systemic effects on carbohydrate and lipid metabolism and is highly responsive to changes in nutrient intake (25) (26) (27) . Circulating concentrations of FGF21 were 4.5fold higher in CTα IKO mice compared to controls after HFD re-feeding ( Fig. 7D ). To test whether the observed changes to circulating hormone concentrations altered postprandial glucose metabolism, we re-fed mice a HFD for 2 h before administering them with an oral glucose challenge. CTα IKO mice had significantly lower peak blood glucose concentrations compared to controls after the glucose challenge (Fig. 7E) . Importantly, re-fed plasma TG and GLP-1 were not different between tamoxifen-treated floxed controls and mice with a heterozygous deletion of intestinal CTα ( Supplementary Fig.S1N and S1O) . These data link impaired lipid uptake in the absence of intestinal CTα to enhanced postprandial enteric and hepatic hormone secretion, likely contributing to reduced body weight in CTα IKO mice relative to control mice.
Loss of intestinal CTα alters enterohepatic circulation of bile acids and increases biliary PC secretion into the intestinal lumen
We were initially surprised that CTα IKO mice can maintain epithelial cell turnover and intestinal viability in the absence of de novo PC synthesis. Thus, we hypothesized that increased biliary PC secretion may contribute to the maintenance of intestinal PC concentrations and intestinal epithelial cell viability in CTα IKO mice. To examine biliary lipid and bile acid secretion, we cannulated the gallbladders of mice fed the HFD. The rate of bile flow in CTα IKO mice was strikingly higher (~25%) than in control mice (Fig. 8A) , coinciding with a doubling of biliary bile acid secretion, a 1.5-fold increase in phospholipid secretion and a 1.3-fold increase in cholesterol secretion (Fig. 8B-8D) . Consistent with increased biliary lyso-PC delivery to the intestinal epithelium, the mRNA levels of jejunal Lpcat4, which catalyzes the addition of oleic acid to lyso-PC (28) , was significantly higher in CTα IKO mice 2 h after HFD re-feeding ( Fig. 8E ).
Therefore, a higher rate of delivery of biliary PC to the intestines of CTα IKO mice may contribute to their capacity to maintain intestinal epithelial cell viability in the absence of de novo intestinal PC synthesis.
While total biliary bile acid concentrations were higher in CTα IKO mice, the bile acid species composition was largely unaltered, except for taurodeoxycholic acid, which was reduced ( Fig. 8F) . Consequently, the bile acid hydrophobicity index was similar between control and CTα IKO mice (Fig. 8G) . Additionally, a non-significant trend towards higher plasma bile acid concentrations in CTα IKO mice fed the HFD was observed (Fig. 8H ). There was no change in the hepatic expression of genes involved in bile acid synthesis, and total fecal bile acid concentrations were not different between CTα IKO mice and control mice fed the HFD (Fig. 8I and 8J). These data strongly indicate that enhanced biliary bile acid and lipid secretion in CTα IKO mice is not driven by an increase in hepatic bile acid synthesis.
There was a robust increase in mRNA levels of the apical sodium-bile acid transporter, solute carrier family 10 member 2 (Slc10a2/Asbt; mainly restricted to the ileum under normal conditions), in the jejunum of CTα IKO mice (Fig. 8K ). An increase in jejunal Asbt is predicted to increase bile acid absorption in the proximal small intestine and to accelerate enterohepatic cycling of bile acids (29) . In line with increased Asbt-mediated bile acid uptake in the proximal small intestine, mRNA levels of the bile-acid transporter Fabp6 had a strong tendency towards an in increase the jejunum of CTα IKO mice compared to controls 2 h after re-feeding. Furthermore, ileal Slc10a2, Fabp6 and Slc51b mRNA levels were not different, while ileal Slc51a were lower in CTα IKO mice than in ileums from control mice. Thus, loss of intestinal CTα stimulates the secretion of bile acids and lipids from the liver by a mechanism that involves a shift in reabsorption of bile acids to the proximal small intestine to promote enterohepatic cycling. 20 
DISCUSSION
In this study we show that intestinal PC synthesis via CTα plays a crucial role in coordinating the metabolic response of mice to HFD feeding. Our data suggest that the metabolic response to a HFD in CTα IKO mice is driven by a combination of impaired dietary lipid absorption, increased secretion of the fat-induced satiety hormones GLP-1 and PYY, and reduced food intake. Furthermore, a shift in expression of bile-acid responsive genes to the proximal small intestine of CTα IKO mice is linked to accelerated enterohepatic bile acid cycling.
Loss of intestinal
CTα is not well tolerated by some mice fed a HFD, indicating that de novo PC synthesis is specifically required for normal intestinal metabolic function. Furthermore, our data
show that re-acylation of lyso-PC from the intestinal lumen cannot compensate for loss of CTαderived PC in enterocytes.
Mice with intestinal deletion of the gene encoding the PC remodeling enzyme Lpcat3
have reduced chylomicron secretion when fed a chow diet due to failure to incorporate polyunsaturated fatty acids into intestinal PC, which alters membrane dynamics and fatty acid uptake (9, 10) . In contrast, we found that de novo PC synthesis is not required for chylomicron secretion in the setting of a low-fat diet. This observation suggests that the re-acylation of lyso-PC derived from bile can fully accommodate chylomicron assembly under these conditions. However, an increase in cellular fatty acid concentrations increases cellular demand for PC to maintain membrane lipid homeostasis and produce the surface monolayer for lipid droplets and lipoproteins (2) . Accordingly, HFD-fed CTα IKO mice have disrupted intestinal metabolic function (likely due to constant influx of fatty acids into intestinal epithelial cells which increases cellular PC demands) including impaired dietary lipid uptake (despite minimal changes to the relative abundance of polyunsaturated PC species or Lpcat3 expression in the intestine). Therefore, both pathways for intestinal PC formation (i.e. de novo PC synthesis and PC remodeling) are independently required for dietary lipid absorption when consuming a HFD.
Furthermore, Lpcat3-deficient mice do not experience changes in bile acid concentrations (10) , suggesting that the pathways of de novo PC synthesis and PC remodeling also control distinct aspects of enterohepatic physiology.
We used a radiolabeled tracer to demonstrate that CTα IKO mice fed a HFD have impaired jejunal fatty acid uptake, resulting in the production of chylomicrons with lower TG content. The intestinal epithelium is highly active in cell division, growth, differentiation, and secretion i.e. processes that require adequate PC supply (2) . Therefore, we were surprised that CTα IKO mice can maintain epithelial cell turnover and intestinal viability in the absence of de novo intestinal PC synthesis. Nevertheless, increased biliary PC secretion may contribute to the maintenance of intestinal PC concentrations in CTα IKO mice. We unexpectedly found that deletion of intestinal CTα doubles the rate of biliary bile acid secretion in CTα IKO mice compared to control mice. Because bile acids drive bile flow as well as biliary cholesterol and phospholipid secretion, these parameters were also significantly higher in CTα IKO mice (31) . The higher rate of 22 delivery of bile acids (with similar composition to bile acids in controls) into the intestinal lumen of CTα IKO mice implies that impaired fatty acid absorption with loss of intestinal CTα is not due to a deficiency of mixed micelles required for efficient fat absorption. Furthermore, since the cholesterol labeling study, the analysis of fecal bile output, and measurement of expression of bile acid-synthetic genes revealed that hepatic bile acid synthesis is not induced by loss of intestinal CTα, enterohepatic cycling of bile acids is likely accelerated. This hypothesis is supported by a shift in expression of Slc10a2 and Fabp6 towards more proximal parts of the small intestine. A shift in the expression of bile-acid responsive genes to the proximal intestine has been reported previously in mice lacking intestinal GATA4, a transcription factor that controls jejunal-ileal identity (32, 33) . The change in spatial expression of bile-acid responsive genes in intestinal GATA4 deficient mice is also linked to impaired lipid absorption (33) and increased bile flow (29) . Clearly, the molecular mechanisms that regulate crosstalk between the intestine and liver in controlling bile formation in CTα IKO mice require further research. Changes to enterohepatic circulation of bile acids can influence lipid, carbohydrate, and energy metabolism (34) . Furthermore, bile acids increase the circulating level of FGF21 (35) , a hepatokine that is increased in CTα IKO mice and that reduces adiposity when administered pharmacologically (25) . Therefore, changes in bile acid metabolism may contribute to metabolic adaptations in the CTα IKO mice fed a HFD.
GLP-1 and PYY are hormones that can influence energy balance through both the enteric nervous system and peripheral targets after nutrient-induced secretion from L cells (24) . Under normal conditions, most dietary fatty acids are absorbed in the proximal small intestine ( Fig.   4C ). However, if high concentrations of fatty acids reach L cells of the distal intestine they can enhance GLP-1 and PYY secretion (24) . Accordingly, mice with intestinal deletion of genes 23 involved in dietary fat absorption, including Mogat2 (13), Dgat1 (36) and Lpcat3 (10) Values are means ± SEM. *p<.05, **p<.01, ***p<.001, ****p<.0001.
